Уважаемые коллеги, доброго времени суток! Представляем вам американское научное издание Women's Health Issues. Журнал имеет первый квартиль, издаётся в Elsevier USA, его SJR за 2022 г. равен 1,122, импакт-фактор 3,1, печатный ISSN - 1049-3867, электронный - 1878-4321, предметные области - Материнство и акушерство, Здравоохранение в социологии, Родовспоможение и гинекология, Общественное здоровье. Вот так выглядит обложка:
Редактором является Карен МакДоннелл, контактные данные - kmcdonne@gwu.edu, whieditor@gwu.edu.
Это рецензируемый раз в два месяца междисциплинарный журнал, в котором публикуются исследования и обзорные рукописи, связанные с охраной здоровья женщин и политикой в этой области. Являясь официальным журналом Института женского здоровья Джейкобса, он посвящен улучшению здоровья и медико-санитарной помощи всем женщинам на протяжении всей жизни и в различных сообществах. Журнал стремится информировать исследователей служб здравоохранения, специалистов в области здравоохранения и общественного здравоохранения, социологов, политиков и других лиц, занимающихся вопросами здоровья женщин.
Адрес издания - https://www.sciencedirect.com/journal/womens-health-issues
Пример статьи, название - Perspectives on Alternative Models of Medication Abortion Provision Among Abortion Patients in the United States. Заголовок (Abstract)
Objective
Restrictions on the availability of medication abortion are a barrier to accessing early abortion. People seeking medication abortion may be interested in obtaining the medications through alternative models. The purpose of this study was to explore patient perspectives on obtaining abortion medications in advance of pregnancy or over the counter (OTC).
Study Design
Between October 2017 and August 2018, we conducted 30 in-depth interviews with abortion patients who indicated support for alternative models. We recruited patients from 10 abortion clinics in states with a range of policy environments. We analyzed interviews using inductive and deductive iterative techniques.
Results
Participants identified logistical benefits of these alternative models, including eliminating travel to a clinic and multiple appointments, and increased privacy around decision-making. Participants were interested in advance provision for its convenience and the sense of preparedness that would come with having the pills available at home, yet some had concerns about the pills being found or stolen. Privacy was the key factor considered for OTC access, including both the privacy benefits of avoiding a clinic and the concern of having one's privacy compromised within the community if purchasing the medications in public.
Conclusions
People who have previously had a medication abortion are interested in alternative methods of provision for reasons concerning convenience, privacy, and avoiding burdens related to hostile policy environments, such as long travel distances to clinics and multiple appointments. Concerns around these models were primarily safety concerns for young people. Further research is needed to evaluate the safety, effectiveness, acceptability, and feasibility of these alternative models of providing medication abortion.